Aurinia Pharmaceuticals
AUPH
#4735
Rank
C$3.14 B
Marketcap
C$24.46
Share price
-1.82%
Change (1 day)
107.15%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): C$0.19 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are C$0.29 Billion. In 2025 the company made an earning of C$0.16 Billion, an increase over its 2024 earnings that were of C$17.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.19 B13.26%
2025 C$0.16 B864.64%
2024 C$17.43 M-116.44%
2023 -C$0.11 Billion-31.8%
2022 -C$0.16 Billion-39.4%
2021 -C$0.26 Billion61.9%
2020 -C$0.16 Billion-9.73%
2019 -C$0.18 Billion92.65%
2018 -C$91.12 Million36.39%
2017 -C$66.81 Million106.29%
2016 -C$32.39 Million-15.4%
2015 -C$38.28 Million65.84%
2014 -C$23.08 Million129.82%
2013 -C$10.05 Million-26.6%
2012 -C$13.69 Million
2010 -C$7.75 Million-39.22%
2009 -C$12.75 Million-43.78%
2008 -C$22.68 Million-53.19%
2007 -C$48.44 Million42.97%
2006 -C$33.88 Million-23.03%
2005 -C$44.02 Million36.1%
2004 -C$32.35 Million172.57%
2003 -C$11.87 Million484.61%
2002 -C$2.03 Million
2000 -C$9.64 Million453.81%
1999 -C$1.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
C$7.31 B 3,636.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-C$31.4 Million-116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-C$7.79 Million-103.97%๐Ÿ‡บ๐Ÿ‡ธ USA